Follow the キッズウェル・バイオ株式会社 stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, キッズウェル・バイオ株式会社 has published 34 insider filings. Market capitalisation: €7.2bn. The latest transaction was disclosed on 29 July 2026 (Holding update). Among the most active insiders: Heights Capital Management, Inc.. Every trade is accessible without an account.
34
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,849 of 29,156 companies
19.3
score / 100
Value
17
Quality
22
FCF yld-14%
Earn yld-5.1%
EV/EBITDA·
ROE-27%
Gross mgn27%
Net mgn-6.3%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.